<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 C:\PWang\Datasets\grobid-0.5.5\grobid-0.5.5\grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.5.5" ident="GROBID" when="2020-06-22T14:03+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">THEMED SECTION: VECTOR DESIGN AND DRUG DELIVERY REVIEW Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2009">2009</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frederic</forename><surname>Heitz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">CRBM-Department of Molecular Biophysics and Therapeutics</orgName>
								<orgName type="laboratory" key="lab1">Centre de Recherches de Biochimie Macromoléculaire</orgName>
								<orgName type="laboratory" key="lab2">UMR 5237</orgName>
								<orgName type="institution">CNRS</orgName>
								<address>
									<addrLine>UM-1, UM-2, 1919 Route de Mende</addrLine>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">May</forename><forename type="middle">Catherine</forename><surname>Morris</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">CRBM-Department of Molecular Biophysics and Therapeutics</orgName>
								<orgName type="laboratory" key="lab1">Centre de Recherches de Biochimie Macromoléculaire</orgName>
								<orgName type="laboratory" key="lab2">UMR 5237</orgName>
								<orgName type="institution">CNRS</orgName>
								<address>
									<addrLine>UM-1, UM-2, 1919 Route de Mende</addrLine>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gilles</forename><surname>Divita</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">CRBM-Department of Molecular Biophysics and Therapeutics</orgName>
								<orgName type="laboratory" key="lab1">Centre de Recherches de Biochimie Macromoléculaire</orgName>
								<orgName type="laboratory" key="lab2">UMR 5237</orgName>
								<orgName type="institution">CNRS</orgName>
								<address>
									<addrLine>UM-1, UM-2, 1919 Route de Mende</addrLine>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">THEMED SECTION: VECTOR DESIGN AND DRUG DELIVERY REVIEW Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics</title>
					</analytic>
					<monogr>
						<title level="j" type="main">British Journal of Pharmacology</title>
						<imprint>
							<biblScope unit="volume">157</biblScope>
							<biblScope unit="page" from="195" to="206"/>
							<date type="published" when="2009">2009</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1111/j.1476-5381.2008.00057.x</idno>
					<note>This article is part of a themed section on Vector Design and Drug Delivery. For a list of all articles in this section see the end of this paper, or visit:</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>cell-penetrating peptide</term>
					<term>non-covalent delivery system</term>
					<term>siRNA</term>
					<term>nanoparticle</term>
					<term>drug delivery</term>
					<term>molecular mechanisms</term>
					<term>therapeutics Abbreviations: CPP, cell-penetrating peptide</term>
					<term>GAG, GlucosAminoGlycan</term>
					<term>NLS, nuclear localization sequence</term>
					<term>PMO, phos- phorodiamidate morpholino-oligomer</term>
					<term>PNA, peptide-nucleic acid</term>
					<term>PTD, protein transduction domains</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The recent discovery of new potent therapeutic molecules that do not reach the clinic due to poor delivery and low bioavailability have made of delivery a key stone in therapeutic development. Several technologies have been designed to improve cellular uptake of therapeutic molecules, including cell-penetrating peptides (CPPs). CPPs were first discovered based on the potency of several proteins to enter cells. Numerous CPPs have been described so far, which can be grouped into two major classes, the first requiring chemical linkage with the drug for cellular internalization and the second involving formation of stable, non-covalent complexes with drugs. Nowadays, CPPs constitute very promising tools for non-invasive cellular import of cargo and have been successfully applied for in vitro and in vivo delivery of therapeutic molecules varying from small chemical molecule, nucleic acids, proteins, peptides, liposomes and particles. This review will focus on the structure/function and cellular uptake mechanism of CPPs in the general context of drug delivery. We will also highlight the application of peptide carriers for the delivery of therapeutic molecules and provide an update of their clinical evaluation.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction: challenges in drug delivery</head><p>Over the past 10 years, in order to circumvent limitations of small molecule-and gene-based therapies, we have witnessed a dramatic acceleration in the production of new large therapeutic molecules, which do not follow Lipinski's rules, such as proteins, peptides and nucleic acid therapeutics. However, their development is restricted by very specific issues including poor stability in vivo, lack of cellular uptake and insufficient capability to reach targets. This is associated with the complete loss of pharmaceutical potency or at least with the requirement for high doses and risk of major side effects. Therefore, delivery constitutes a major piece of the therapeutic puzzle, and there is a real demand for new and more efficient drug delivery systems. Major rules have to be satisfied, in particular: (i) delivery efficiency in different and challenging cell lines; (ii) rapid endosomal release; (iii) ability to reach the target; (iv) activity at low doses; (v) lack of toxicity; and (vi) facility of therapeutic application.</p><p>Substantial progress has been made in the design of new technologies to improve cellular uptake of therapeutic compounds <ref type="bibr" target="#b113">(Opalinska and Gewirtz, 2002;</ref><ref type="bibr" target="#b59">Järver and Langel, 2004;</ref><ref type="bibr" target="#b51">Glover et al., 2005;</ref><ref type="bibr" target="#b140">Torchilin, 2005;</ref><ref type="bibr" target="#b18">De Fougerolles et al., 2007;</ref><ref type="bibr" target="#b70">Kong and Mooney, 2007)</ref>. A number of non-viral strategies have been proposed including lipid, polycationic, nanoparticle and peptide-based formulations as reported in this special issue <ref type="bibr" target="#b92">(Morris et al., 2000;</ref><ref type="bibr" target="#b112">Ogris and Wagner, 2002;</ref><ref type="bibr" target="#b59">Järver and Langel, 2004;</ref><ref type="bibr" target="#b140">Torchilin, 2005)</ref>, but only a subset of these technologies are efficiently applied in vivo at either preclinical or clinical levels. Protein transduction domains (PTDs) or cell-penetrating peptides (CPPs) correspond to short 30 residue synthetic peptides and are part of the most promising strategy to overcome both extracellular and intracellular limitations of various biomolecules of including plasmid DNA, oligonucleotide, siRNA, peptide-nucleic acid (PNA), proteins, peptides as well as liposomes. CPPs can trigger the movement of a cargo across the cell membrane into the cytoplasm of cells and improve its intracellular routing, thereby facilitating interactions with the target <ref type="bibr" target="#b19">(Derossi et al., 1994;</ref><ref type="bibr" target="#b38">Fawell et al., 1994;</ref><ref type="bibr" target="#b120">Pooga et al., 1998;</ref><ref type="bibr" target="#b147">Wender et al., 2000;</ref><ref type="bibr" target="#b23">Deshayes et al., 2005;</ref><ref type="bibr" target="#b85">Meade and Dowdy, 2007;</ref><ref type="bibr" target="#b97">Morris et al., 2008)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell-penetrating peptide families</head><p>Twenty years ago, the notion of PTD was proposed based on the observation that some proteins, mainly transcription factors, could shuttle within the cell and from one cell to another. Historically, the first observation was made in 1988, by <ref type="bibr">Frankel and Pabo, who</ref> showed that the transcriptiontransactivating (Tat) protein of HIV-1 could enter cells and translocate into the nucleus <ref type="bibr" target="#b44">(Frankel and Pabo, 1988)</ref>. In 1991, the group of Prochiantz demonstrated that Drosophila Antennapedia homeodomain could be internalized by neuronal cells <ref type="bibr" target="#b61">(Joliot et al., 1991)</ref>, work which was at the origin of the discovery in 1994 of the first PTD or CPP: a 16-merpeptide derived form the third helix of the homeodomain of Antennapedia termed penetratin (RQIKIYFQNRRMKWKK) <ref type="bibr" target="#b19">(Derossi et al., 1994)</ref>. In 1998 the group of Lebleu identified the minimal peptide sequence of Tat required for cellular uptake ( 47 YGRKKRRQRRR 57 ) <ref type="bibr" target="#b144">(Vives et al., 1997)</ref>. In 1997, the first non-covalent CPP for delivery of nucleic acids MPG was designed by the group of Heitz and Divita <ref type="bibr" target="#b90">(Morris et al., 1997)</ref> closely followed by development of Pep-1 for non-covalent cellular delivery of proteins and peptides <ref type="bibr" target="#b93">(Morris et al., 2001)</ref>. The groups of Wender and of Futaki demonstrated that polyarginine sequences (Arg8) were sufficient to drive molecules into cells and proposed that their uptake mechanism involves a bidentate hydrogen-bonding interaction between guanidinium group of arginine residues and phosphate group in the membrane <ref type="bibr" target="#b147">(Wender et al., 2000;</ref><ref type="bibr" target="#b46">Futaki et al., 2001)</ref>. A major breakthrough in the CPP field came from the first proofs-of-concept of their in vivo application, by the groups of Dowdy, for the delivery of small peptides and large proteins <ref type="bibr" target="#b132">(Schwarze et al., 1999)</ref>, and of Langel, for delivery of PNAs using the chimeric peptide Transportan, derived form the N-terminal fragment of the neuropeptide galanin, linked to mastoparan, a wasp venom peptide <ref type="bibr" target="#b120">(Pooga et al., 1998)</ref>. Ever since many other CPPs able to trigger the movement of a cargo across the cell membrane into the cytoplasm have been designed <ref type="bibr" target="#b59">(Järver and Langel, 2004;</ref><ref type="bibr" target="#b60">Joliot and Prochiantz, 2004;</ref><ref type="bibr" target="#b23">Deshayes et al., 2005;</ref><ref type="bibr" target="#b134">Snyder and Dowdy, 2005)</ref>. CPPs are generally peptides of less than 30 amino acids, derived from natural or unnatural protein or chimeric sequences and can be subdivided into two main classes, the first requiring chemical linkage with the cargo and the second involving formation of stable, non-covalent complexes. CPPs can also be distinguished from a structural point of view, as either polycationic, essentially containing clusters of polyarginine in their primary sequence or amphipathic. The representative CPPs are reported in <ref type="table" target="#tab_0">Table 1</ref>. Although this review mainly focuses on CPPs based on natural amino acids, recent new concepts of CPPs containing unnatural and modified residues have been proposed in order to improve either the stability or the efficiency of the carrier (Farrera-Sinfreu et al., 2007). Covalent strategy Cell-penetrating peptide-based technologies described so far mainly involve the formation of a covalent conjugate between the cargo and the carrier peptide, which is achieved by chemical cross-linking or by cloning followed by expression of a CPP fusion protein <ref type="bibr" target="#b106">(Nagahara et al., 1998;</ref><ref type="bibr" target="#b47">Gait, 2003;</ref><ref type="bibr" target="#b100">Moulton and Moulton, 2004;</ref><ref type="bibr" target="#b150">Zatsepin et al., 2005)</ref>. Most of the work has been reported for peptides derived from Tat <ref type="bibr" target="#b38">(Fawell et al., 1994;</ref><ref type="bibr" target="#b144">Vives et al., 1997;</ref><ref type="bibr" target="#b44">Frankel and Pabo, 1988)</ref>, penetratin <ref type="bibr" target="#b19">(Derossi et al., 1994)</ref>, polyarginine peptide Arg8 sequence <ref type="bibr" target="#b147">(Wender et al., 2000;</ref><ref type="bibr" target="#b46">Futaki et al., 2001)</ref> and Transportan, <ref type="bibr" target="#b120">(Pooga et al., 1998)</ref>. Other protein-derived peptides such as VP22 protein from Herpes Simplex Virus <ref type="bibr" target="#b30">(Elliott and O'Hare, 1997)</ref>, pVec <ref type="bibr" target="#b31">(Elmquist et al., 2001)</ref>, calcitoninderived peptides <ref type="bibr" target="#b131">(Schmidt et al., 1998;</ref><ref type="bibr" target="#b73">Krauss et al., 2004)</ref>, antimicrobial peptides Buforin I and SynB <ref type="bibr" target="#b117">(Park et al., 1998;</ref><ref type="bibr" target="#b116">Park et al., 2000)</ref>, as well as polyproline sweet arrow peptide <ref type="bibr" target="#b122">(Pujals et al., 2006)</ref> have also been successfully used to improve the delivery of covalently linked cargos <ref type="bibr" target="#b60">(Joliot and Prochiantz, 2004;</ref><ref type="bibr" target="#b28">El-Andaloussi et al., 2005;</ref><ref type="bibr" target="#b104">Murriel and Dowdy, 2006)</ref>. More recently, new generations of CPPs, combining different transduction motifs <ref type="bibr" target="#b1">(Abes et al., 2007)</ref> or transduction domains in tandem with protein or oligonucleotide-binding domains <ref type="bibr" target="#b85">(Meade and Dowdy, 2007)</ref> have been proposed. Different chemistries have been proposed for stable or cleavable conjugation involving mainly disulfide or thio-esters linkages. According to the stability and efficiency of the cargo, several parameters need to be considered including the type of linkage chemistry, the nature of the spacer <ref type="bibr" target="#b47">(Gait, 2003;</ref><ref type="bibr" target="#b150">Zatsepin et al., 2005)</ref>. Covalent strategies have been mainly reported for the delivery of DNA mimic molecules or steric block oligonucleotides, including PNA <ref type="bibr" target="#b72">(Koppelhus et al., 2002;</ref><ref type="bibr" target="#b35">Fabani et al., 2008)</ref>, phosphorodiamidate morpholino-oligomer (PMO) <ref type="bibr" target="#b0">(Abes et al., 2006;</ref><ref type="bibr" target="#b77">Lebleu et al., 2008;</ref><ref type="bibr" target="#b101">Moulton and Moulton, 2008)</ref>, peptide and protein <ref type="bibr" target="#b134">(Snyder and Dowdy, 2005)</ref>. Conjugation methods offer several advantages for in vivo applications including rationalization, reproducibility of the procedure, together with the control of the stoechiometry of the CPP-cargo. However, the covalent CPP technology is limited from a chemical point of view and risks altering the biological activity of the cargo. This is particularly true, in the case of charged oligonucleotide or siRNA, for which CPP coupling has led to restricted biological activities <ref type="bibr" target="#b62">(Juliano et al., 2008)</ref>, noncovalent strategies thereby appearing more appropriate.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Non-covalent strategy</head><p>This strategy is mainly based on short amphipathic peptide carriers consisting of two domains: a hydrophilic (polar) domain and a hydrophobic (non-polar) domain <ref type="table" target="#tab_0">(Table 1</ref>). The amphipathic character may arise from either the primary structure or the secondary structure. Primary amphipathic peptides can be defined as the sequential assembly of a domain of hydrophobic residues with a domain of hydrophilic residues. Secondary amphipathic peptides are generated by the conformational state that allows positioning of hydrophobic and hydrophilic residues on opposite sides of the molecule <ref type="bibr" target="#b23">(Deshayes et al., 2005)</ref>. Several CPPs have been reported to form non-covalent complexes with biomolecules and to improve their delivery into mammalian cells . Non-covalent approach was originally developed for gene delivery; several peptides able to condense DNA associated with peptides that favour endosomal escape including fusion peptide of HA 2 subunit of influenza hemaglutinin have been described <ref type="bibr" target="#b76">(Lear and Degrado, 1987;</ref><ref type="bibr" target="#b115">Parente et al., 1990)</ref>. Synthetic peptides analogs GALA, KALA, JTS1 <ref type="bibr" target="#b53">(Gottschalk et al., 1996;</ref><ref type="bibr" target="#b149">Wyman et al., 1997)</ref>, PPTG1 <ref type="bibr" target="#b126">(Rittner et al., 2002)</ref>, MPG <ref type="bibr" target="#b91">(Morris et al., 1999)</ref> and histidine-rich peptides <ref type="bibr" target="#b88">(Midoux et al., 1998;</ref><ref type="bibr" target="#b64">Kichler et al., 2003)</ref> were also reported as potent gene delivery systems. In 2001, we demonstrated that the amphipathic peptide Pep-1 could be successfully applied to the delivery of small peptides and proteins in a non-covalent approach <ref type="bibr" target="#b93">(Morris et al., 2001)</ref>. In 2003, a non-covalent strategy based on MPG was shown to efficiently deliver siRNA into cultured cell lines <ref type="bibr" target="#b133">(Simeoni et al., 2003)</ref>. Pep-1 and MPG are primary amphipathic peptides containing a hydrophilic lysine-rich domain derived from the nuclear localization sequence (NLS) of SV40 large T antigen (KKKRKV), and a variable N-terminal hydrophobic moiety derived form the fusion sequence of the HIV protein gp41 (GALFLGFLGAAG-STMGA) for MPG, and from a tryptophan-rich cluster (KETW-WETWWTEW) for Pep-1, separated by a linker domain, which improves the flexibility and the integrity of both the hydrophobic and hydrophilic domains <ref type="bibr" target="#b90">(Morris et al., 1997;</ref><ref type="bibr" target="#b91">Morris et al., 1999;</ref><ref type="bibr" target="#b133">Simeoni et al., 2003)</ref>. MPG and Pep-1 form stable complexes with their respective cargo (oligonucleotide or protein/peptide) through non-covalent electrostatic and hydrophobic interactions <ref type="bibr" target="#b90">(Morris et al., 1997;</ref><ref type="bibr" target="#b133">Simeoni et al., 2003;</ref><ref type="bibr" target="#b54">Gros et al., 2006;</ref><ref type="bibr" target="#b102">Munoz-Morris et al., 2007)</ref>. Non-covalent strategies for protein and oligonucleotide delivery have been recently been extended to other CPPs, including Tat <ref type="bibr" target="#b85">(Meade and Dowdy, 2007)</ref>, polyarginine <ref type="bibr" target="#b67">(Kim et al., 2006;</ref><ref type="bibr" target="#b75">Kumar et al., 2007)</ref> and Transportan-derived peptides <ref type="bibr" target="#b121">(Pooga et al., 2001;</ref><ref type="bibr" target="#b80">Lundberg et al., 2007)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cellular uptake mechanism of cell-penetrating peptides</head><p>The cellular uptake mechanism of CPPs is an essential piece of the puzzle for the development and optimization of appropriate strategies for in vivo therapeutic applications. Although cellular internalization of CPPs was reported in a wide variety of cell types, their mechanism of internalization remained 'mysterious' for a long time, as being independent of endocytosis, of energy and of specific receptor. In the last 5 years, the CPP field has suffered and learnt from technical artifacts. As such, in 2003, Lebleu and colleagues, proposed a revised cellular uptake mechanism for CPPs, essentially associated with the endosomal pathway <ref type="bibr" target="#b124">(Richard et al., 2003)</ref>. Ever since, the mechanism of many CPPs has re-examined and reported to be mediated by endocytosis <ref type="bibr" target="#b79">(Lundberg and Johansson, 2001;</ref><ref type="bibr" target="#b107">Nakase et al., 2004;</ref><ref type="bibr" target="#b146">Wadia et al., 2004;</ref><ref type="bibr" target="#b40">Fischer et al., 2005;</ref><ref type="bibr" target="#b125">Richard et al., 2005;</ref><ref type="bibr" target="#b104">Murriel and Dowdy, 2006)</ref>. However, for most CPPs, the cellular uptake mechanism still needs to be confirmed and remains controversial, partly due to the fact that different methods, which are not comparable from one lab Peptide-based drug delivery technology F Heitz et al to another, have been employed to this aim. Therefore, results should be taken with care as in most of the cases the visualization of CPPs inside the cell is based on fluorescein-labelled CPPs with the risk that fluorescent dyes may alter the uptake mechanism or trigger an unusual cell entry pathway, which does not reflect the biologically active fraction of the CPPs or of the cargo. Evidence for several routes of entry has been reported, some of which are independent of the endosomal pathway and involve the trans-membrane potential <ref type="bibr" target="#b138">(Terrone et al., 2003;</ref><ref type="bibr" target="#b139">Thoren et al., 2003;</ref><ref type="bibr" target="#b127">Rothbard et al., 2004;</ref><ref type="bibr" target="#b23">Deshayes et al., 2005)</ref>. Therefore, for therapeutic purposes the challenge remains in identifying the route yielding a biological response, which may not be the predominant one and to correlate the uptake pathway with a biological response associated with a specific cargo <ref type="bibr" target="#b146">(Wadia et al., 2004;</ref><ref type="bibr" target="#b54">Gros et al., 2006)</ref>. For that purpose, several approaches have been described, by using biological reporters <ref type="bibr" target="#b146">(Wadia et al., 2004;</ref><ref type="bibr" target="#b77">Lebleu et al., 2008)</ref> or phenotypic <ref type="bibr" target="#b95">(Morris et al., 2007a</ref>) assays enabling to follow shuttling and release of the cargo in real time in cultured cells <ref type="bibr" target="#b78">(Lee et al., 2008)</ref> or in animal models <ref type="bibr" target="#b148">(Wender et al., 2007)</ref> Although it remains difficult to establish a general scheme for CPP uptake mechanism, there is a consensus that the first contacts between the CPPs and the cell surface take place through electrostatic interactions with proteoglycans, and that the cellular uptake pathway is driven by several parameters including: (i) the nature and secondary structure of the CPP; (ii) its ability to interact with cell surface and membrane lipid components; (iii) the nature, type and active concentration of the cargo; and (iv) the cell type and membrane composition <ref type="figure" target="#fig_0">(Figure 1)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Role of proteoglycans</head><p>Proteoglycans play an essential role in the regulation of cell surface microdomains, and evidence for direct relationships between cytoskeletal organization and activation of small GTPases has been clearly established <ref type="bibr" target="#b13">(Conner and Schmid, 2003;</ref><ref type="bibr" target="#b27">Eitzen, 2003)</ref>. Heparan sulfate proteoglycans and syndecans are the major components of the extracellular matrix, and their clustering triggers cytoskeletal remodelling upon activation of protein kinase C and Rho/Rac GTPases, which control the dynamics of cholesterol-rich 'raft' microdomains, and therefore ligand binding and cellular uptake pathways <ref type="bibr" target="#b15">(Couchman, 2003;</ref><ref type="bibr" target="#b4">Beauvais and Rapraeger, 2004)</ref>. The first contacts between the CPPs and the cell surface take place through electrostatic binding with cell surface proteoglycans GlucosAminoGlycan (GAG) platform, follow by a remodelling of the actin network and a selective activation of the (1) Binding of CPPs or CPP/cargo complexes to extracellular matrix via the cell surface proteoglycan platform, (2) clustering of GlucosAminoGlycan platform triggers selective activation of small GTPase and remodelling of the actin network, (3) increase of membrane fluidity or microdomain dynamic promotes the cell entry and release in the cytosol of CPP-NCS and of CPP-CS (at high concentrations) via membrane fusion or cellular uptake of CPP-CS/CPP-NCS via (4) endocytosis pathway (a: caveolindependent, b: clathrin-dependent, c: clathrin-and caveolin-independent) or (5) macropinocytosis. After endocytic capture, CPP-CS can escape from lysosomal degradation and enter the cytosol and the nucleus (6), remain in the early or late endosomes (7), or be delivered in the Golgi apparatus and the endoplasmic reticulum (8).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Peptide-based drug delivery technology</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="198">F Heitz et al</head><p>small GTPase Rho A or Rac1 <ref type="bibr" target="#b26">(Duchardt et al., 2007;</ref><ref type="bibr" target="#b152">Ziegler, 2008)</ref>. GTPase activation and actin remodelling constitute the 'onset' of the internalization mechanism and have a major impact on membrane fluidity, thereby promoting cell entry of Arg 8 , penetratin and Tat via macropinocytosis <ref type="bibr" target="#b108">(Nakase et al., 2007)</ref> or clathrin-dependent endocytosis <ref type="bibr" target="#b125">(Richard et al., 2005)</ref>, of MPG or Pep-1 particles via membrane perturbation mechanism <ref type="bibr" target="#b50">(Gerbal-Chaloin et al., 2007)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The gates of the cells: cell entry and trafficking pathways</head><p>Following binding to the GAG 'platform', which facilitates accumulation of the CPP and CPP-cargo complexes at the cell surface, different cell entry gates have been reported depending on the CPPs. Correlation of cellular uptake with a cargoassociated biological response is a major requirement to validate the efficiency of a CPP, as originally established for Tat <ref type="bibr" target="#b146">(Wadia et al., 2004)</ref> and has been extended to series of wellknown CPPs <ref type="bibr" target="#b107">(Nakase et al., 2004;</ref><ref type="bibr" target="#b114">Padari et al., 2005)</ref>. One of the major differences between CPPs resides in their mode of interaction with the cellular surface components. The interaction of peptides such as Tat <ref type="bibr" target="#b14">(Console et al., 2003;</ref><ref type="bibr" target="#b104">Murriel and Dowdy, 2006)</ref> polyarginine and penetratin <ref type="bibr" target="#b107">(Nakase et al., 2004;</ref><ref type="bibr" target="#b86">2007)</ref> with the extracellular matrix has been reported to be primarily electrostatic and to trigger uptake through an energy-dependent endocytotic process <ref type="bibr" target="#b130">(Rusnati et al., 1999;</ref><ref type="bibr" target="#b104">Murriel and Dowdy, 2006)</ref>. Although, macropinocytosis has been reported as the major route of internalization of cationic CPPs <ref type="bibr" target="#b146">(Wadia et al., 2004;</ref><ref type="bibr" target="#b63">Kaplan et al., 2005)</ref>, other endocytotic pathways including clathrin-and caveolin-dependent endocytosis <ref type="bibr" target="#b125">(Richard et al., 2005;</ref><ref type="bibr" target="#b153">Ziegler et al., 2005)</ref> and transGolgi network-mediated internalization <ref type="bibr" target="#b40">(Fischer et al., 2005)</ref> have been described for CPPs. Moreover, different mechanisms of membrane translocation and endocytosis may concur simultaneously for most CPPs. This is especially true for amphipathic peptides, which tend to interact with lipids and adopt secondary structures within the membrane that modified membrane integrity. The secondary structure of CPPs and their dynamics constitute major factors in the mechanism of cellular uptake <ref type="bibr" target="#b82">(Magzoub and Gräslund, 2004;</ref><ref type="bibr" target="#b23">Deshayes et al., 2005;</ref><ref type="bibr" target="#b32">Esbjorner et al., 2007)</ref>. Increasing the local concentration of CPPs at the cell surface favours cellular uptake independently of endocytosis and leads to a more cytoplasmic distribution of CPPs. Indeed, the major route for cell entry of CPP-based nanoparticles, such as Pep-1 and MPG has been shown to be independent of the endosomal pathway. Cellular uptake is associated with the ability of MPG and Pep-1 to interact with membrane lipids, mainly through their hydrophobic domain, and to form transient trans-membrane helical or beta structures that temporarily affect membrane organization, thereby facilitating insertion into the membrane and initiation of the translocation process associated with membrane potential <ref type="bibr">(Deshayes et al., 2004a,b)</ref>. Cellular uptake of biologically active Pep-1 or MPG/cargo complexes is directly correlated with the structure of the nanoparticle that creates a local high concentration of peptides at the cell surface <ref type="bibr" target="#b54">(Gros et al., 2006;</ref><ref type="bibr" target="#b102">Munoz-Morris et al., 2007)</ref>.</p><p>In contrast, to cellular uptake that is well characterized for a subset of CPPs, very little is known about their cellular trafficking, which is important to allow the cargo to reach its target within the cell. Clearly, endosomal escape remains a major limitation and the rate-limiting step of CPP-mediated drug delivery. A small fraction of CPPs is able to escape from the endosome throughout either their endosomal breaker property or to the fact of the poor integrity of the macropinocytosis vesicles. Several studies report that CPPs can traffic through the endoplasmic reticulum and the Golgi network via a 'retrograde pathway' that involves cytosolic release <ref type="bibr" target="#b40">(Fischer et al., 2005)</ref>. Moreover, CPPs harbouring functional NLS motif can directly localize and trigger cargo in the nucleus <ref type="bibr" target="#b11">(Cartier and Reszka, 2002;</ref><ref type="bibr" target="#b133">Simeoni et al., 2003)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Application of CPP strategies to the delivery of therapeutic molecules</head><p>The number of applications using CPPs is consciously increasing, and so far more than 300 studies using either covalent or non-covalent CPP-based strategies from in vitro to in vivo have been reported <ref type="bibr" target="#b25">(Dietz and Bähr, 2004;</ref><ref type="bibr" target="#b54">Gros et al., 2006;</ref><ref type="bibr" target="#b99">Moschos et al., 2007;</ref><ref type="bibr" target="#b118">Patel et al., 2007;</ref><ref type="bibr" target="#b43">Foerg and Merkle, 2008)</ref>. The interest for CPPs is mainly due to their low cytotoxicity and to the fact that there is no limitation for the type of cargo. Although CPPs have been used to improve delivery of cargo that varies greatly in size and nature (small molecules, oligonucleotide, plasmid DNA, peptide, protein, nanoparticle, lipid-based formulation, virus, quantum dots) most of the applications describe the delivery of oligopeptide/protein <ref type="bibr" target="#b25">(Dietz and Bähr, 2004;</ref><ref type="bibr" target="#b54">Gros et al., 2006;</ref><ref type="bibr" target="#b118">Patel et al., 2007)</ref> and nucleic acids or analogs <ref type="bibr" target="#b62">(Juliano et al., 2008)</ref>  <ref type="table" target="#tab_0">(Table 1)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CPP-based strategies for gene delivery</head><p>The poor permeability of the plasma membrane of eukaryotic cells to DNA together with the low efficiency of DNA or oligonucleotides to reach their target within cells constitutes the two major barriers for the development of these therapeutic molecules. In the last decade, a number of peptide carriers that combine DNA binding, mainly electrostatic domain (polylysine and polyarginine) and membrane-destabilizing properties have been developed to facilitate gene transfer into cultured cells and living animals <ref type="bibr" target="#b111">(Niidome and Huang, 2002;</ref><ref type="bibr" target="#b51">Glover et al., 2005;</ref><ref type="bibr" target="#b97">Morris et al., 2008)</ref>. Amphipathic peptides with pH-dependent fusogenic and endosomolytic activities such as the fusion peptide of HA 2 subunit of influenza hemaglutinin, or synthetic analogs GALA, KALA, JTS1, and histidine-rich peptides have been shown to increase transfection efficiency when associated with poly-L-lysine/DNA, condensing peptide/DNA, cationic lipids, poly-ethyleneimine or polyamidoamine cascade polymers (for review: <ref type="bibr" target="#b97">Morris et al., 2008)</ref>. Single peptide chains able to condense DNA and to favour endosomal escape (PPTG1) <ref type="bibr" target="#b126">(Rittner et al., 2002)</ref> or prevent endosomal uptake (MPG: <ref type="bibr" target="#b91">Morris et al., 1999)</ref> have also been used for gene delivery in cultured cells. However, only a few CPPs have been validated in vivo for gene delivery and so far, the secondary amphipathic peptide PPTG1 constitutes one of the only examples reporting a significant in vivo gene expression response following intravenous injection <ref type="bibr" target="#b126">(Rittner et al., 2002)</ref>. Tat, Transportan and polyarginine CPPs have Peptide-based drug delivery technology F Heitz et al been associated with other lipid-based non-viral gene delivery methods, including liposomes, PEI or nanostructures <ref type="bibr" target="#b6">(Branden et al., 1999;</ref><ref type="bibr" target="#b142">Tung et al., 2002;</ref><ref type="bibr" target="#b58">Ignatovich et al., 2003;</ref><ref type="bibr" target="#b129">Rudolph et al., 2003;</ref><ref type="bibr" target="#b65">Kilk et al., 2005)</ref>. The association of Tat and octa-arginine to pharmaceutical nano-carriers, described as non-viral delivery systems based on new packing concepts 'Programmed packaging' Multifunctional Envelope-type NanoDevice (MEND) <ref type="bibr" target="#b69">(Kogure et al., 2004;</ref><ref type="bibr" target="#b81">MacKay et al., 2008)</ref>, has been shown to improve gene delivery and to offer the advantage of combining delivery, packaging and targeting motifs within the same particle <ref type="bibr" target="#b141">(Torchilin, 2008 ;</ref><ref type="bibr" target="#b145">Vivès et al., 2008)</ref>.</p><p>The second major barrier of non-viral gene delivery systems is their poor nuclear translocation, which is however essential for transfection of non-dividing cells and gene therapy. In order to improve nuclear delivery of DNA-plasmids, synthetic peptides containing NLS have been extensively applied <ref type="bibr" target="#b11">(Cartier and Reszka, 2002;</ref><ref type="bibr" target="#b33">Escriou et al., 2003)</ref>. Most of these studies were performed with the sequence derived from SV40 large T antigen NLS (PKKKRKV). This sequence was associated with either membrane-penetrating or cationic peptides, but also directly linked to cargoes or combined with other transfection methods to facilitate delivery into the nucleus. Moreover, NLS sequences have been associated with different hydrophobic CPPs in order to favour nuclear targeting as well as DNA binding and compaction. The NLS domain of MPG has been shown to improve the nuclear translocation of nucleic acids without requiring nuclear membrane breakdown during mitosis. MPG technology has been applied to both plasmid DNA and oligonucleotide delivery with high efficiency into a large number of adherent and suspension cell lines <ref type="bibr" target="#b133">(Simeoni et al., 2003;</ref><ref type="bibr" target="#b96">Morris et al., 2007b)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CPP-based strategies for oligonucleotide analog delivery</head><p>Steric block small neutral oligonucleotide including PNAs and phosphorodiamidate morphorodiamidate morpholinooligomers (PMO) constitute potent molecules for either antisense application or mRNA splicing correction strategies. Several CPPs have been successfully applied for the delivery of uncharged PNA and PMO in vitro and in vivo through covalent coupling <ref type="bibr" target="#b47">(Gait, 2003;</ref><ref type="bibr" target="#b100">Moulton and Moulton, 2004;</ref><ref type="bibr" target="#b150">Zatsepin et al., 2005;</ref><ref type="bibr" target="#b62">Juliano et al., 2008)</ref>. Originally reported with Transportan for in vivo delivery of an antisense PNA targeting galanine receptors and modifying pain transmission <ref type="bibr" target="#b120">(Pooga et al., 1998)</ref>, the use of CPPs for steric block oligonucleotide delivery has been extended to Tat, penetratin, TP10 (a short version of Transportan) and arginine-rich peptides. Several CPP-based covalent approaches have been reported for the delivery of antisense PNA <ref type="bibr" target="#b71">(Koppelhus and Nielsen, 2003)</ref>. However only a few have been used in vivo, and until recently none of them were reported to be active at submicromolar concentrations <ref type="bibr" target="#b47">(Gait, 2003;</ref><ref type="bibr" target="#b1">Abes et al., 2007)</ref>. A detailed study of CPP-mediated PNA delivery has reported that the major limitation is due to their endosomal sequestration <ref type="bibr" target="#b71">(Koppelhus and Nielsen, 2003)</ref>, and more recently new CPPs have been described by Lebleu and Gait groups including R6-penetratin and 6-aminohexanoic acid spaced oligoarginine [(R-Ahx-R) 4], which exhibit limited endosomal sequestration and lead to submicromolar antisense or splicing correction response <ref type="bibr" target="#b0">(Abes et al., 2006;</ref><ref type="bibr" target="#b86">2007)</ref>. These CPPs have been validated in vivo for splicing correction on two therapeutic models: Duchenne's muscular dystrophy <ref type="bibr" target="#b42">(Fletcher et al., 2007)</ref> and coronavirus replication in mice <ref type="bibr" target="#b9">(Burrer et al., 2007)</ref>. Non-covalent strategies have also been applied to the delivery of PNA and DNA mimic molecules <ref type="bibr" target="#b109">(Nan et al., 2005)</ref>. Pep-3 peptide, a variant of Pep-1, was successfully applied to the delivery of PNA and analogs targeting the cell cycle regulatory protein cyclin B1 in vitro and in vivo <ref type="bibr" target="#b96">2007b)</ref>. Interestingly, the nanoparticle organization of Pep-3/PNA complex allows functionalization of the surface layer of the particle, and PEGylation of the carrier significantly improves the efficacy of the response by stabilizing the complexes. This study shows that such a modification improves Pep-3 for systemic administration into mice, thereby allowing for a significant reduction of the dose required to induce a specific and robust biological response, which consequently limits non-specific cytotoxic effects described upon treatment with high concentrations of CPP-PNA conjugate or non-covalenty complexes <ref type="bibr" target="#b96">(Morris et al., 2007b)</ref>.</p><p>Oligonucleotide and siRNA delivery Decoy oligonucleotides and short interfering RNAs (siRNA) constitute powerful biomedical tools to control protein activation and/or gene expression post-transcriptionally. <ref type="bibr" target="#b29">(Elbashir et al., 2001;</ref><ref type="bibr" target="#b56">Hannon, 2002</ref>). However, the major limitation of siRNA applications, like most antisense or nucleic acid-based strategies remains their poor cellular uptake associated with the poor permeability of the cell membrane to nucleic acids. Several viral and non-viral strategies have been proposed to improve the delivery of either siRNAexpressing vectors or synthetic siRNAs both in cultured cells and in vivo <ref type="bibr" target="#b18">(De Fougerolles et al., 2007;</ref><ref type="bibr" target="#b62">Juliano et al., 2008)</ref>. CPP-based strategies have been developed to improve the delivery of oligonucleotides both in vitro and in vivo. Delivery of charged oligonucleotide and siRNA is more challenging as multiple anionic charges of the nucleic acid interact with CPP moiety and inhibit uptakes by steric hindrance. Delivery of charged oligonucleotide was achieved by using either peptidebased non-covalent or PNA-hybridization strategies. In the latter, CPPs are covalently linked to a PNA that is able to hybridize with a double-stranded decoy oligonucleotide containing on one strand a flanking sequence complementary to the PNA. Strategies have been applied with Transportan and TP10 CPP for the delivery of decoy oligonucleotide interacting with NFkB or Myc <ref type="bibr" target="#b41">(Fisher et al., 2004;</ref><ref type="bibr" target="#b28">El-Andaloussi et al., 2005)</ref>. The MPG peptide-based delivery system has been successfully applied for the delivery of various type of nucleic acid, including phosphodiester-oligonucleotide targeting the protein phosphatase cdc25C <ref type="bibr" target="#b91">(Morris et al., 1999)</ref>, phosphorothioate-oligonucleotides targeting MDR-1 promoter in human CEM leukaemia cells <ref type="bibr" target="#b84">(Marthinet et al., 2000)</ref> and thio-phosphoramidate telomerase template antagonists in cancer cells <ref type="bibr" target="#b55">Gryaznov et al., 2003)</ref>. Several CPP-based strategies have been used for the delivery of siRNA into cultured cells. siRNA covalently linked to Transportan <ref type="bibr" target="#b103">(Muratovska and Eccles, 2004)</ref> and penetratin <ref type="bibr" target="#b17">(Davidson et al., 2004)</ref> have been associated with a silencing response. Nevertheless, non-covalent strategies appear to be more appropriate for siRNA delivery and yield significant associated  <ref type="bibr" target="#b133">(Simeoni et al., 2003;</ref><ref type="bibr" target="#b67">Kim et al., 2006;</ref><ref type="bibr" target="#b143">Veldhoen et al., 2006;</ref><ref type="bibr" target="#b16">Crombez et al., 2007;</ref><ref type="bibr" target="#b75">Kumar et al., 2007;</ref><ref type="bibr" target="#b80">Lundberg et al., 2007;</ref><ref type="bibr" target="#b85">Meade and Dowdy, 2007)</ref>. MPG peptide has been reported to improve siRNA delivery into a large panel of cell lines including adherent cell lines, cells in suspension, cancer and challenging primary cell lines <ref type="bibr" target="#b133">(Simeoni et al., 2003;</ref><ref type="bibr" target="#b89">Morris et al., 2004a;</ref><ref type="bibr" target="#b110">Nguyen et al., 2006)</ref>. MPG has been applied for in vivo delivery of siRNA targeting OCT-4 into mouse blastocytes <ref type="bibr" target="#b151">(Zeineddine et al., 2006)</ref> and of siRNA targeting an essential cell cycle protein, cyclin B1; intravenous injection of MPG/cyclin B1 siRNA particles has been shown to efficiently block tumour growth <ref type="bibr" target="#b16">(Crombez et al., 2007)</ref>. A variant of MPG (MPG-alpha) harbouring five mutations in the hydrophobic domain, in order to favour helical conformation of the peptide, has also been shown to improve siRNA delivery <ref type="bibr" target="#b143">(Veldhoen et al., 2006)</ref>. However, such modifications of MPG increase toxicity and favour endosomal cellular uptake <ref type="bibr" target="#b22">(Deshayes et al., 2004c;</ref><ref type="bibr" target="#b143">Veldhoen et al., 2006)</ref>. This non-covalent approach has been extended to other CPPs including polyarginine- <ref type="bibr" target="#b67">(Kim et al., 2006;</ref><ref type="bibr" target="#b75">Kumar et al., 2007)</ref>, penetratin- <ref type="bibr" target="#b80">(Lundberg et al., 2007)</ref> and Tat- <ref type="bibr" target="#b85">(Meade and Dowdy, 2007)</ref> derived peptides. Tat peptide associated with an RNA-binding motif has been reported to block in vivo epidermal growth factor (EGF) factor, cholesterol-Arg9 has been shown to enhance siRNA delivery in vivo against vascular endothelial growth factors <ref type="bibr" target="#b67">(Kim et al., 2006)</ref> and more recently, a small peptide derived from rabies virus glycoprotein associated to polyarginine R9 has been shown to deliver siRNA in the CNS <ref type="bibr" target="#b75">(Kumar et al., 2007)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CPP-based strategies for in vivo delivery of proteins and peptides</head><p>In order to circumvent the technological problems of gene delivery an increasing interest has been taken in designing novel strategies to enable delivery of peptides and full-length proteins into a large numbers of cells. The first proof of concept of the in vivo potency of CPPs was provided by Dowdy and colleagues in 1999, showing that Tat-bgalactosidase fusion protein can be delivered into almost all tissues including the brain, following intra-peritoneal injection into mice <ref type="bibr" target="#b132">(Schwarze et al., 1999)</ref>. Over the last decade, CPP-based delivery has been successfully used to deliver peptides and proteins to target different diseases including cell proliferation/cancer, asthma, apoptosis, ischaemia, stimulating cytotoxic immunity and diabetes <ref type="bibr" target="#b25">(Dietz and Bähr, 2004;</ref><ref type="bibr" target="#b134">Snyder and Dowdy, 2005;</ref><ref type="bibr" target="#b54">Gros et al., 2006)</ref>. Most of these applications use CPPs (Tat, penetratin, polyarginine, VP22) covalently linked to peptides or as fusion proteins. More recently, in vivo applications of Pep-1 technology have been described including intravenous, intra-tumoural and intratracheal injections, as well as transduction into oocytes, sprays for nasal delivery or direct penetration through the skin <ref type="bibr" target="#b54">(Gros et al., 2006;</ref><ref type="bibr" target="#b97">Morris et al., 2008)</ref>. One of the principal applications of CPPs involves the delivery of peptides and proteins for cancer and anti-proliferation treatments. The tumour suppressor p53 constitutes a choice target, and different p53-derived peptides covalently linked to CPPs have been demonstrated to restore p53 functions in cancer cells. Tatmediated delivery of a peptide derived form the C-terminus of p53 reduces tumour growth upon intra-peritoneal injection into mice with b-cell lymphoma <ref type="bibr" target="#b135">(Snyder et al., 2004;</ref><ref type="bibr" target="#b137">Tang et al., 2007)</ref>. Similarly, PNC-28, a peptide derived from the MDM-2-binding domain of p53 linked to penetratin has been described to block tumour growth <ref type="bibr" target="#b87">(Michl et al., 2006;</ref><ref type="bibr" target="#b5">Bowne et al., 2007)</ref>. Another successful anti-proliferation application has been reported using a peptide derived from the N-terminus of the Smac protein, which inactivates the inhibitor of apoptosis protein <ref type="bibr" target="#b66">(Kim et al., 1999)</ref>. Smac peptide associated to CPPs sensitizes cells to pro-apoptotic stimulus and a synergetic effect of Smac peptide and TNF-related apoptosis inducing ligand has been shown on intracranial glioblastoma xenografted mice <ref type="bibr" target="#b45">(Fulda et al., 2002)</ref>. Peptides and protein domains derived from natural protein inhibitors (p16 Ink , p21, p15 or p27 kip ) of cyclin-dependent kinases involved in cell cycle progression have been used to block cancer cell proliferation. A tumour suppressor function in vivo was reported by using p27 kip tumour suppressor protein genetically coupled to Tat <ref type="bibr" target="#b106">(Nagahara et al., 1998;</ref><ref type="bibr" target="#b135">Snyder et al., 2004)</ref>, as well as a p16</p><p>Ink -derived peptide associated to penetratin <ref type="bibr" target="#b57">(Hosotani et al., 2002)</ref>. Small peptide inhibitors of cyclin-dependent kinase activation have been delivered by using the noncovalent Pep-1-based approach and shown to block cancer cell proliferation <ref type="bibr" target="#b52">(Gondeau et al., 2005)</ref>. CPPs have also been used to target B-cell lymphoma oncogene. A peptide for EBV 'Epstein Barr Virus' associated to Tat blocks proliferation <ref type="bibr" target="#b68">(Knight et al., 2006)</ref>. Tat-mediated BCL6 peptide inhibitor delivery has been reported to modulate B-cell phenotype <ref type="bibr" target="#b119">(Polo et al., 2004;</ref><ref type="bibr" target="#b86">Melnick, 2007)</ref>. Pep-1 strategy was also applied to the evaluation of the antitumoural activity of peptide inhibitors of protein kinases or to repair a defective step in a cellular signalling pathway in vivo <ref type="bibr" target="#b54">(Gros et al., 2006;</ref><ref type="bibr" target="#b97">Morris et al., 2008)</ref>.</p><p>Deregulation of apoptosis has been directly or indirectly associated with many pathologies. Several successful applications of CPP-assisted delivery of proteins or peptides regulating apoptosis have been reported. Tat-FLIP (caspase 8 inhibitor) fusion peptide interferes with the activation of FAS inducing signalling complex, thereby preventing apoptosis in vivo <ref type="bibr" target="#b74">(Krautwald et al., 2004)</ref>. A peptide issued from the Bcl2 homology domain 4 (BH4) or Bcl2/Bclxl protein associated with Tat can regulate apoptosis and induce cytoprotection in vivo <ref type="bibr" target="#b136">(Sugioka et al., 2003)</ref>. Survivin mutants associated with Tat facilitate apoptosis in cancer cells <ref type="bibr" target="#b146">(Wadia et al., 2004)</ref>. Pep-1 strategy has been applied in vivo to the delivery of proteins into the lungs of mice to produce alveolar wall apoptosis or to correct defects in protein kinase A function <ref type="bibr" target="#b2">(Aoshiba et al., 2003;</ref><ref type="bibr" target="#b83">Maron et al., 2005)</ref>.</p><p>The ability of CPPs to cross the blood brain barrier and to favour the delivery of proteins in the brain has been used to improve the outcome of ischaemic events. Death of neuronal cells following cerebral ischaemia is associated with apoptosis, and Tat-Bclxl protein can be delivered into mouse brain to decrease neuronal cell death in the area of ischaemic damages <ref type="bibr" target="#b10">(Cao et al., 2002)</ref>. Reduction of cerebral ischaemia and protection of ischaemia in brain injury has been reported with Tat-cJNK peptide, Tat-NMR2 and Tat-Bclx protein <ref type="bibr" target="#b10">(Cao et al., 2002)</ref>. Tat-dV-1 peptide, a selective inhibitor of PKCg has been Peptide-based drug delivery technology F Heitz et al reported to attenuate heart ischaemia <ref type="bibr" target="#b7">(Bright et al., 2004)</ref>. CPPs have also been used for the delivery of small molecules through the blood brain barrier, as such D-penetratin or SynB1 have been reported to significantly increase uptake of doxorubicine into the brain <ref type="bibr" target="#b128">(Rousselle et al., 2001)</ref>. Pep-1 technology has also been demonstrated to be a potent strategy to deliver therapeutic proteins in vivo and across the blood brain barrier <ref type="bibr" target="#b49">(Gallo et al., 2002;</ref><ref type="bibr" target="#b2">Aoshiba et al., 2003;</ref><ref type="bibr" target="#b48">Gallo, 2003;</ref><ref type="bibr" target="#b83">Maron et al., 2005;</ref><ref type="bibr" target="#b54">Gros et al., 2006)</ref>.</p><p>Cell-penetrating peptides have also been used for the treatment of asthma, by using dominant negative forms of Ras or phopshoinositol 3 kinase (Pi3K) fused to Tat to inhibit the airway inflammatory response by cytokine blockage in a mouse <ref type="bibr" target="#b105">(Myou et al., 2003)</ref>. Different proteins and peptides coupled with Tat and penetratin have been used for immunization against specific infectious diseases. Tat peptide has also been used for the delivery of modular antigen molecules useful for treatment of allergy and vaccine production <ref type="bibr" target="#b123">(Rhyner et al., 2007)</ref>. Superoxide dismutase (SOD) fused to Tat or to Pep-1 has been shown to protect pancreatic beta cells against oxidative stress <ref type="bibr" target="#b34">(Eum et al., 2004)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical evaluation of CPP-based delivery strategies</head><p>Numerous preclinical and clinical evaluations of CPP-based delivery approaches are currently under evaluation. The first, CPP clinical trial was initiated a few years ago by Cell Gate Inc. for topical delivery of cyclosporine linked to polyarginine and entered phase II trials in 2003 <ref type="bibr" target="#b127">(Rothbard et al., 2004)</ref>. Ever since, several companies are working on clinical development of CPPs, for topical and systemic administration of different therapeutic molecules. Avi Biopharma for the in vivo steric block splicing correction using 6-aminohexanoic acid spaced oligoarginine [(R-Ahx-R)4] <ref type="bibr" target="#b77">(Lebleu et al., 2008;</ref><ref type="bibr" target="#b101">Moulton and Moulton, 2008)</ref>. Kai Pharmaceutical <ref type="bibr" target="#b12">(Chen and Harrison, 2007</ref>) is currently evaluating a Tat protein kinase C inhibitor peptide modulator of protein kinase C for acute myocardial infraction and cerebral ischaemia, which entered phase II in 2007. Other companies including Traversa Inc., for Tat-based non-covalent siRNA delivery, Panomics Inc., for secondary amphipathic peptide-based non-covalent delivery of siRNA are currently evaluating CPP at preclinical and clinical trials.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p>The dramatic acceleration in the discovery of new and highly potent therapeutic molecules, which do however not make it to the clinic due to poor delivery, low bioavailability and lack of rational targeting has made it clear that delivery was a key stone in therapeutic development <ref type="bibr" target="#b70">(Kong and Mooney, 2007)</ref>. Accordingly, carrier peptides represent a new and innovative concept to bypass problems of bioavailability associated with certain drugs such as peptides, proteins and nucleic acids, which are currently rarely considered as therapeutics due to the above-mentioned limitations. Such peptide-based strategies present several advantages, including rapid delivery of cargoes into cells with very high efficiency, stability in physiological buffers, lack of toxicity and of sensitivity to serum. Twenty years after their discovery, CPPs are at the door of the clinic. The success reported on the preclinical evaluation of CPPs during the last decade has revealed a tremendous potential of clinical treatment. Covalent strategy has been validated for protein and peptide delivery, and the recent success of phases I and II clinical trials has open great hope in the used of CPPs for therapy. Moreover, the introduction of the CPPbased non-covalent strategy has allowed the introduction of oligonucleotide and siRNA on preclinical states. The lack of prerequisites for covalent coupling upon formation of carrier/ macromolecule particles favours the intracellular routing of the cargo and enables its controlled release into the target cellular compartment. Whatever the nature of the delivery system, a major attention should be paid to the targeting of the carrier/drug in order to mediate drug delivery into specific cell types and to limit its dispersion in the whole body.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc>Figure 1 Model of cellular uptake and intracellular trafficking of cell-penetrating peptides (CPPs). Cellular uptake of CPP by the covalent (CPP-CS) and non-covalent (CPP-NCS) strategies. (1) Binding of CPPs or CPP/cargo complexes to extracellular matrix via the cell surface proteoglycan platform, (2) clustering of GlucosAminoGlycan platform triggers selective activation of small GTPase and remodelling of the actin network, (3) increase of membrane fluidity or microdomain dynamic promotes the cell entry and release in the cytosol of CPP-NCS and of CPP-CS (at high concentrations) via membrane fusion or cellular uptake of CPP-CS/CPP-NCS via (4) endocytosis pathway (a: caveolindependent, b: clathrin-dependent, c: clathrin-and caveolin-independent) or (5) macropinocytosis. After endocytic capture, CPP-CS can escape from lysosomal degradation and enter the cytosol and the nucleus (6), remain in the early or late endosomes (7), or be delivered in the Golgi apparatus and the endoplasmic reticulum (8).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" validated="true"><head>Table 1</head><label>1</label><figDesc>Representative CPPs: sequences, applications and major related references</figDesc><table>Peptides 

Origin 

Sequences 

Cargo types 

References 

Peptides deriving from protein transduction domains 

Tat 

HIV-Tat protein 

PGRKKRRQRRPPQ 

Protein/peptide/siRNA/ 
liposome/nanoparticle 
Snyder and Dowdy (2005); 
Schwarze et al. (1999) 

Penetratin 

Homeodomain 

RQIKIWFQNRRMKWKK 

peptide/siRNA/liposome 
Joliot and Prochiantz (2004) 

Transportan 

Galanin-mastoparan 

GWTLNSAGYLLGKINLKALAALAKKIL 

Protein/PNA/siRNA 

Pooga et al. (1998) 

VP-22 

HSV-1 structural protein 

DAATATRGRSAASRPTERPRAPAR-SASRPRRPVD 

Protein 

Elliott and O'Hare (1997) 

Amphipathic peptides 

MPG 

HIV Gp41-SV40 NLS 

GALFLGFLGAAGSTMGAWSQPKKKRKV 

siRNA/ODN/plasmid 

Morris et al. (2008) 

Pep-1 

Trp-rich motif-SV40 NLS 

KETWWETWWTEWSQPKKKRKV 

Protein/peptide 

Gros et al. (2006) 

MAP 

Chimeric 

KALAKALAKALA 

Small molecule/plasmid 

SAP 

Proline-rich motif 

VRLPPPVRLPPPVRLPPP 

protein/peptide 

Pujals et al. (2006) 

PPTG1 

Chimeric 

GLFRALLRLLRSLWRLLLRA 

Plasmid 

Rittner et al. (2002) 

Other cell-penetrating peptides: cationic peptides 
Oligoarginine 

Chimeric 

Agr8 or Arg9 

Protein/peptide/siRNA/ODN 
Wender et al. (2000); Futaki 

et al. (2001) 

hCT (9-32) 

Human calcitonin 

LGTYTQDFNKTFPQTAIGVGAP 

Protein/plasmid DNA 

Schmidt et al. (1998) 

SynB 

Protegrin 

RGGRLSYSRRRFSTSTGR 

Doxorubicin 

Rousselle et al. (2001) 

Pvec 

Murine VE-cadherin 

LLIILRRRIRKQAHAHSK 

Protein/peptide </table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">British Journal of Pharmacology (2009) 157 195-206</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>This work was supported in part by the Centre National de la Recherche Scientifique (CNRS), Active Motif (Carlsbad, CA), Panomics Inc. (Fremont, CA) and by grants from the Agence Nationale de Recherche (ANR: Grant ANR-06-BLAN-0071) and the EU (Grant QLK2-CT-2001-01451 &amp; Grant LSHB-CT-2003-503480/TRIoH). We thank members of the laboratory and our collaborators for fruitful discussions.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflitct of interest</head><p>None.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Abes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">M</forename><surname>Moulton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Clair</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Prevot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Youngblood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">P</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Control Release</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="304" to="313" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Abes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">D</forename><surname>Ivanova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Owen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Arzumanov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="4495" to="4502" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Alveolar wall apoptosis causes lung destruction and amphysematous changes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Aoshiba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Yokohori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nagai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Cell Mol Biol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="555" to="561" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">A novel telomerase template antagonist (GRN163) as a potential anticancer agent</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Asai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Oshima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Uochi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kusaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Akinaga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="3931" to="3939" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Syndecans in tumor cell adhesion and signalling</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">M</forename><surname>Beauvais</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">C</forename><surname>Rapraeger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Reprod Biol Endocrinol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="3" to="5" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">B</forename><surname>Bowne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Michl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Bluth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Zenilman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Pincus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Ther</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="331" to="344" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">A peptide nucleic acidnuclear localization signal fusion that mediates nuclear transport of DNA</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Branden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Mohamed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">I</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="784" to="787" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Protein kinase C delta mediates cerebral reperfusion injury in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Bright</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">P</forename><surname>Raval</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Dembner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Pérez-Pinzón</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">K</forename><surname>Steinberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Yenari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="6880" to="6888" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">British Journal of Pharmacology</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="195" to="206" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Burrer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">W</forename><surname>Neuman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Ting</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">M</forename><surname>Moulton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">L</forename><surname>Iversen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="5637" to="5648" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">R</forename><surname>Sharp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="5423" to="5431" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Cartier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Reszka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="157" to="163" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Cell-penetrating peptides in drug development: enabling intracellular targets</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">D</forename><surname>Harrison</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Soc Trans</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="821" to="825" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Regulated portals of entry into the cell</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">D</forename><surname>Conner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Schmid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">422</biblScope>
			<biblScope unit="page" from="37" to="44" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Antennapedia and HIV transactivator of transcription (TAT) &apos;protein transduction domains&apos; promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Console</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Marty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Garcia-Echeverria</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Schwendener</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ballmerhofer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="35109" to="35114" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Syndecans: proteoglycan regulators of cellsurface microdomains?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Couchman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="926" to="937" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">A non-covalent peptide-based strategy for siRNA delivery</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Crombez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Charnet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Aldrian-Herrada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Soc Trans</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="44" to="46" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Harel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">A</forename><surname>Arboleda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">F</forename><surname>Prunell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Shelanski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">A</forename><surname>Greene</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="10040" to="10046" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Interfering with desease: a progress report on siRNA-based therapeutics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>De Fougerolles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H-P</forename><surname>Vornlocher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Maraganore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lieberman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Disc</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="443" to="453" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The third helix of the Antennapedia homeodomain translocates through biological membranes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Derossi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">H</forename><surname>Joliot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Chassaing</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Prochiantz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="10444" to="10450" />
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Insight into the mechanism of internalization of the cellpenetrating carrier peptide Pep-1 through conformational analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Deshayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Charnet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1449" to="1457" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Deshayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gerbal-Chaloin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Aldrian-Herrada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Charnet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1667</biblScope>
			<biblScope unit="page" from="141" to="147" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Deshayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Plénat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Aldrian-Herrada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Le</forename><surname>Grimellec</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="7698" to="7706" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Cell-penetrating peptides: tools for intracellular delivery of therapeutics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Deshayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Mol Life Sci</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="1839" to="1849" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Deshayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Drug Deliv Rev</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="537" to="547" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Delivery of bioactive molecules into the cell: the Trojan horse approach</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">P</forename><surname>Dietz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Bähr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Neurosci</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="85" to="131" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">A comprehensive model for the cellular uptake of cationic cellpenetrating peptides</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Duchardt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Fotin-Mleczek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Brock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Traffic</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="848" to="866" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Actin remodelling to facilitate membrane fusion</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Eitzen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1641</biblScope>
			<biblScope unit="page" from="175" to="181" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Cell-penetrating peptides: mechanism and applications</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>El-Andaloussi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Holm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ü</forename><surname>Langel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cur Pharma Design</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="3597" to="3611" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Elbashir</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Harborth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Lendeckel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Yalcin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Tuschl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">411</biblScope>
			<biblScope unit="page" from="494" to="498" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Intercellular trafficking and protein delivery by a Herpesvirus structural protein</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>O&amp;apos;hare</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="223" to="233" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">VE-cadherinderived cell-penetrating peptide, pVEC, with carrier functions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Elmquist</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Lindgren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Bartfai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Langel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="237" to="244" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main">Membrane interactions of cell penetrating peptide</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">K</forename><surname>Esbjorner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Gräslung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Nordën</surname></persName>
		</author>
		<editor>Langel Ü</editor>
		<imprint>
			<date type="published" when="2007" />
			<publisher>CRC press</publisher>
			<biblScope unit="page" from="109" to="138" />
			<pubPlace>Boca Raton, FL</pubPlace>
		</imprint>
	</monogr>
	<note>Cell-Penetrating Peptides</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">NLS bioconjugates for targeting therapeutic genes to the nucleus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Escriou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Carriere</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Scherman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Wils</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Drug Deliv Rev</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="295" to="306" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">S</forename><surname>Eum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">K</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">C</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Jang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Free Radic Biol Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1656" to="1669" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Peptide-Peptide Nucleic Acid conjugates for modulation of gene expression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Fabani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">D</forename><surname>Ivanova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Gait</surname></persName>
		</author>
		<editor>Kurreck J</editor>
		<imprint>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Therapeutic</forename><surname>Oligonucleotide</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Royal Society of Chemistry</title>
		<imprint>
			<biblScope unit="page" from="80" to="102" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Cell-penetrating proline-rich peptidomimetics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Farrera-Sinfreu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Giralt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Royo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Albericio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods Mol Biol</title>
		<imprint>
			<biblScope unit="volume">386</biblScope>
			<biblScope unit="page" from="241" to="267" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Fawell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Seery</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Daikh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Pepinsky</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Tat-mediated delivery of heterologous proteins into cells</title>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="664" to="668" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Fotin-Mleczek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Hufnagel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Brock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chembiochem</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="2126" to="2142" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Cellular delivery of a double-stranded oligonucleotide NFkappaB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Soomets</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cortés</forename><surname>Toro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Chilton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Langel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Iverfeldt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1264" to="1272" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Honeyman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Fall</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">L</forename><surname>Harding</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">D</forename><surname>Johnsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Steinhaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1587" to="1592" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">On the biomedical promise of cell penetrating peptides: limits versus prospects</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Foerg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">P</forename><surname>Merkle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharm Sci</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="144" to="162" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Cellular uptake of the tat protein from human immunodeficiency virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">D</forename><surname>Frankel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">O</forename><surname>Pabo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1189" to="1193" />
			<date type="published" when="1988" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Smac agonists sensitize for Apo2L/TRAIL-or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Fulda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Wick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Weller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Debatin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="808" to="815" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Arginine-rich peptides. An abundant source of membranepermeable peptides having potential as carriers for intracellular protein delivery</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Futaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Ohashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Yagami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ueda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="page" from="5836" to="5840" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Gait</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Mol Life Sci</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="844" to="853" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Making proteins into drugs: assisted delivery of proteins and peptides into living neurons</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Gallo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods Cell Biol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="325" to="338" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Gallo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">F</forename><surname>Yee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Letourneau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biol</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="1219" to="1228" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">First step of the cell-penetrating peptide mechanism involves Rac1 GTPase-dependent actinnetwork Remodelling</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gerbal-Chaloin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Gondeau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Aldrian-Herrada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Gauthierrouvière</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Cell</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="223" to="238" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Towards safe, non-viral therapeutic gene expression in humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Glover</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">J</forename><surname>Lipps</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Jans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Genet</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="299" to="310" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Gondeau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gerbal-Chaloin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Bello</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Aldrian-Herrada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="13793" to="13800" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gottschalk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Sparrow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Hauer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">P</forename><surname>Mims</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">E</forename><surname>Leland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Woo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="448" to="457" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">A non-covalent peptide-based strategy for protein and peptide nucleic acid delivery</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Gros</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Deshayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Aldrian-Herrada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Depollier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1758</biblScope>
			<biblScope unit="page" from="384" to="393" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Oligonucleotide N3′ -&gt; P5′ thio-phosphoramidate telomerase template antagonists as potential anticancer agents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gryaznov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Asai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Oshima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Pongracz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Pruzan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleosides Nucleotides Nucleic Acids</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="577" to="581" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">RNA interference</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">J</forename><surname>Hannon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">418</biblScope>
			<biblScope unit="page" from="244" to="251" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Hosotani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Miyamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Doi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Otaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Fujii</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1271" to="1276" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Complexes of plasmid DNA with basic domain 47-57.of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">A</forename><surname>Ignatovich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">B</forename><surname>Dizhe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">V</forename><surname>Pavlotskaya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">N</forename><surname>Akifiev</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">V</forename><surname>Burov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">V</forename><surname>Orlov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="42625" to="42636" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">The use of cell-penetrating peptides as a toll for gene regulation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Järver</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ü</forename><surname>Langel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Discov Today</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="395" to="402" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Transduction peptides: from technology to physiology</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Joliot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Prochiantz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Cell Biol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="189" to="196" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Antennapedia homeobox peptide regulates neural morphogenesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Joliot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Pernelle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Deagostini-Bazin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Prochiantz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="1864" to="1868" />
			<date type="published" when="1991" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Juliano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Alam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Dixit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="4158" to="4171" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Cationic Tat peptide transduction domain enters cells by macropinocytosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">M</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Wadia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F</forename><surname>Dowdy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Control Release</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="247" to="253" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Histidinerich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Kichler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Leborgne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>März</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Danos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Bechinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="1564" to="1568" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Evaluation of transportan 10 in PEI mediated plasmid delivery assay</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kilk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>El-Andaloussi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Järver</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Meikas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Valkna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Bartfai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Control Release</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="511" to="523" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">L</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Raffo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">W</forename><surname>Brandt-Rauf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Pincus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Monaco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Abarzua</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">274</biblScope>
			<biblScope unit="page" from="34924" to="34931" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">V</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jo</forename><forename type="middle">S</forename><surname>Yockman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">W</forename><surname>Jeong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="343" to="350" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">A peptide-based inhibitor for prevention of B cell hyperproliferation induced by Epstein-Barr virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Lan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Bajaj</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">S</forename><surname>Robertson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="volume">354</biblScope>
			<biblScope unit="page" from="207" to="214" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kogure</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Moriguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ueno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Futaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Harashima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Control Release</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="317" to="323" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Microenvironmental regulation of biomacromolecular therapies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Mooney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Discov</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="455" to="463" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Cellular Delivery of peptide nucleic acid</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Koppelhus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">E</forename><surname>Nielsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Drug Del Rev</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="267" to="280" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Koppelhus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Awasthi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Zachar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">U</forename><surname>Holst</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Ebbesen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">E</forename><surname>Nielsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antisense Nucleic Acid Drug Dev</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="51" to="63" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Krauss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">G</forename><surname>Beck-Sickinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioorg Med Chem Lett</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="51" to="65" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Transduction of the TAT-FLIP fusion protein results in transient resistance to Fas-induced apoptosis in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Krautwald</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Ziegler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Tiede</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Pust</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Kunzendorf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="44005" to="44011" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Transvascular delivery of small interfering RNA to the central nervous system</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Mcbride</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">E</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">L</forename><surname>Davidson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">7149</biblScope>
			<biblScope unit="page" from="39" to="43" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Lear</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">F</forename><surname>Degrado</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">262</biblScope>
			<biblScope unit="page" from="6500" to="6510" />
			<date type="published" when="1987" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Cell penetrating peptide conjugates of steric block oligonucleotides</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Lebleu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">M</forename><surname>Moulton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Abes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">D</forename><surname>Ivanova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Abes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Stein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Drug Deliv Rev</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="517" to="529" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Single-molecule motions of oligoarginine transporter conjugates on the plasma membrane of Chinese hamster ovary cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Dubikovskaya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">N</forename><surname>Semyonov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">R</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="9364" to="9370" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Is VP22 nuclear homing an artefact?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Lundberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Johansson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="713" to="714" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Delivery of short interfering RNA using endosomolytic cellpenetrating peptides</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Lundberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>El-Andaloussi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Sutlu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Johansson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Langel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="2664" to="2671" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">E</forename><surname>Dy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Huynh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Tihan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="893" to="900" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Cell-penetrating peptides: small from inception to application</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Magzoub</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Gräslund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Q Rev Biophys</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="147" to="195" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">PKA delivery to the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced alveolar epithelial PKA desensitization</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">B</forename><surname>Maron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">G</forename><surname>Folkesson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Stader</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Walro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Lung Cell Mol Physiol</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="349" to="354" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Marthinet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Bernaud</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Rigal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">G</forename><surname>Baggetto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1224" to="1233" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">R</forename><surname>Meade</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F</forename><surname>Dowdy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Drug Deliv Rev</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="134" to="140" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Targeting aggressive B-cell lymphomas with cellpenetrating peptides</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Melnick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Soc Trans</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="802" to="806" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Michl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Scharf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Huynh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Hannan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Von Gizycki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="1577" to="1585" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Membrane permeabilization and efficient gene transfer by a peptide containing several histidines</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Midoux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Kichler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Boutin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Maurizot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Monsigny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioconjug Chem</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="260" to="267" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Small interfering RNA-induced transcriptional gene silencing in human cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">V</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">E</forename><surname>Jacobsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Looney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="1289" to="1292" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">A new peptide vector for efficient delivery of oligonucleotides into mammalian cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Vidal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Chaloin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="2730" to="2736" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">A novel potent strategy for gene delivery using a single peptide vector as a carrier</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Chaloin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Mery</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="3510" to="3517" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Translocating peptides and proteins and their use for gene delivery</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Chaloin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Biotechnol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="461" to="466" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">A peptide carrier for the delivery of biologically active proteins into mammalian cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Depollier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Mery</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1173" to="1176" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Combination of a new generation of PNAs with a peptidebased carrier enables efficient targeting of cell cycle progression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Chaloin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Choob</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Archdeacon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="757" to="764" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<monogr>
		<title level="m" type="main">A noncovalent peptide-based strategy for peptide and short interfering RNA delivery</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Deshayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Simeoni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Aldrian-Herrada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
		<editor>Langel Ü (ed.</editor>
		<imprint>
			<date type="published" when="2007" />
			<publisher>CRC press</publisher>
			<biblScope unit="page" from="387" to="408" />
			<pubPlace>Boca Raton, FL</pubPlace>
		</imprint>
	</monogr>
	<note>Cell-Penetrating Peptides</note>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">A non-covalent peptide-based carrier for in vivo delivery of DNA mimics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Gros</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Aldrian-Herrada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Choob</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Archdeacon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="49" to="59" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Cell-penetrating peptides: from molecular mechanisms to therapeutics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Deshayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Cell</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="201" to="217" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">British Journal of Pharmacology</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="195" to="206" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<monogr>
		<title level="m" type="main">In vivo applications of Cell-Penetrating peptide</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Moschos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Lindsay</surname></persName>
		</author>
		<editor>Langel Ü</editor>
		<imprint>
			<date type="published" when="2007" />
			<publisher>CRC press</publisher>
			<biblScope unit="page" from="423" to="438" />
			<pubPlace>Boca Raton, FL</pubPlace>
		</imprint>
	</monogr>
	<note>Cell-Penetrating Peptides</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Arginine-rich cell-penetrating peptides with uncharged antisense oligomers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">M</forename><surname>Moulton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Moulton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Discov Today</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="870" to="875" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<monogr>
		<title level="m" type="main">Antisense morpholino oligomers and theirs peptide conjugates</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">M</forename><surname>Moulton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Moulton</surname></persName>
		</author>
		<editor>Kurreck J (ed.). Therapeutic Oligonucleotide</editor>
		<imprint>
			<date type="published" when="2008" />
			<publisher>Royal Society of Chemistry</publisher>
			<biblScope unit="page" from="43" to="79" />
			<pubPlace>Cambridge</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Munoz-Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">355</biblScope>
			<biblScope unit="page" from="877" to="882" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Muratovska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Eccles</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">558</biblScope>
			<biblScope unit="page" from="63" to="68" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Influence of protein transduction domains on intracellular delivery of macromolecules</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">L</forename><surname>Murriel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F</forename><surname>Dowdy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Opin Drug Deliv</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="739" to="746" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Activation of group IV cytosolic phospholipase A2 in human eosinophils by phosphoinositide 3-kinase through a mitogen-activated protein kinase-independent pathway</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Myou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Leff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Myo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Boetticher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">Y</forename><surname>Meliton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">T</forename><surname>Lambertino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page" from="4399" to="4405" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Transduction of full-length TAT fusion proteins into mammalian cells: TAp27 kip1 induced cell migration</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Nagahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Vocero-Akbani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">L</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">G</forename><surname>Latham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">A</forename><surname>Lissy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1449" to="1453" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Nakase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Niwa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Sonomura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Kawabata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Koike</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1011" to="1022" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Interaction of arginine-rich peptides with membraneassociated proteoglycans is crucial for induction of actin organization and macropinocytosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Nakase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Tadokoro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Kawabata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Katoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Hiramoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="492" to="501" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">RNA interference of VCP/p97 increases Mallory body formation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Nan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Bardag-Gorce</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Mol Pathol</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Light controllable siRNAs regulate gene suppression and phenotypes in cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><forename type="middle">N</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">V</forename><surname>Chavli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Marques</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Jr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">G</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1758</biblScope>
			<biblScope unit="page" from="394" to="403" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Gene therapy progress and prospects: non viral vectors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Niidome</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1647" to="1652" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Targeting tumors with non-viral gene delivery systems</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ogris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Wagner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Discov Today</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="479" to="485" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Nucleic-acid therapeutics: basic principles and recent applications</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Opalinska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Gewirtz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Discov</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="503" to="516" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
	<note>Nucleic-acid therapeutics: basic principles and recent applications</note>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Cell transduction pathways of transportans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Padari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Saalik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Koppel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Raid</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Langel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioconjug Chem</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1399" to="1410" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Association of a pH-sensitive peptide with membrane vesicles: role of amino acid sequence</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Parente</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Nadasdi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">K</forename><surname>Subbarao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">C</forename><surname>Szoka</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="8713" to="8719" />
			<date type="published" when="1990" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">B</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Yi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Matsuzaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad USA</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="8245" to="8250" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">An antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">Y</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">B</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Parasin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">437</biblScope>
			<biblScope unit="page" from="258" to="262" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">N</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Zaro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharm Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1977" to="1992" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Polo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Dell&amp;apos;oso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Ranuncolo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Cerchietti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Da</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1329" to="1335" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pooga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Soomets</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Hallbrink</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Valkna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Saar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Rezaei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="857" to="861" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Cellular translocation of proteins by transportan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pooga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Kut</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kihlmark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Hallbrink</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Fernaeus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Raid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1451" to="1453" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Pujals</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Fernandez-Carneado</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Lopez-Iglesias</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Kogan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Giralt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1758</biblScope>
			<biblScope unit="page" from="264" to="279" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Targeting the MHC II presentation pathway in allergy vaccine development</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Rhyner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kündig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Akdis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Crameri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Soc Trans</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="833" to="834" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
	<note>Pt 4</note>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Richard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Melikov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Vives</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ramos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Verbeure</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Gait</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="585" to="590" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Richard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Melikov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Prevot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Lebleu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Chernomordik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="15300" to="15306" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Rittner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Benavente</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Bompard-Sorlet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Brasseur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="104" to="114" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Rothbard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">C</forename><surname>Jessop</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">S</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">A</forename><surname>Wender</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="9506" to="9507" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Rousselle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Smirnova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Clair</forename><forename type="middle">P</forename><surname>Lefauconnier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Chavanieu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Calas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharmacol Exp Ther</title>
		<imprint>
			<biblScope unit="volume">296</biblScope>
			<biblScope unit="page" from="124" to="131" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Rudolph</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Plank</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lausier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Schillinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Rosenecker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="11411" to="11418" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Rusnati</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Tulipano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Spillmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Tanghetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Oreste</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Zoppetti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">274</biblScope>
			<biblScope unit="page" from="28198" to="28205" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Translocation of human calcitonin in respiratory nasal epithelium is associated with self assembly in lipid membrane</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Rothen-Rutishauser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Rist</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Beck-Sickinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Wunderli-Allenspach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Rubas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="16582" to="16590" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">In vivo protein transduction: delivery of a biologically active protein into the mouse</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Schwarze</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Vocero-Akbani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F</forename><surname>Dowdy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="1569" to="1572" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Simeoni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Divita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="2717" to="2724" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">L</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F</forename><surname>Dowdy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Opin Drug Deliv</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="43" to="51" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">L</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">R</forename><surname>Meade</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Saenz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F</forename><surname>Dowdy</surname></persName>
		</author>
		<idno>E36.</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS Biol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Sugioka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Funatsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Tamagawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Sawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kawakami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="8432" to="8440" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">p53 short peptide regulateds lipopolysaccharide -induced tumor necrosis factor-a-factor/ cytokine expression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Molina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Amar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="1308" to="1316" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Penetratin and related Peptide-based drug delivery technology F Heitz et al cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Terrone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Sang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Roudaia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Silvius</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="13787" to="13799" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">E</forename><surname>Thoren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Persson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Isakson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Goksor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Onfelt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Norden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">307</biblScope>
			<biblScope unit="page" from="100" to="107" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Recent advances with liposomes as pharmaceutical carriers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">P</forename><surname>Torchilin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Discov</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="145" to="160" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">P</forename><surname>Torchilin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Drug Deliv Rev</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="548" to="558" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Novel branching membrane translocational peptide as gene delivery vector</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">H</forename><surname>Tung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Weissleder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioorg Med Chem</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="3609" to="3614" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Cellular delivery of small interfering RNA by a noncovalenty attached cell-penetrating peptide: quantitative analysis of uptake and biological effect</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Veldhoen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">D</forename><surname>Laufer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Trampe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Restle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="6561" to="6573" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Vives</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Brodin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Lebleu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="page" from="16010" to="16017" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Cell-penetrating and celltargeting peptides in drug delivery</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Vivès</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Pèlegrin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1786</biblScope>
			<biblScope unit="page" from="126" to="138" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Wadia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">V</forename><surname>Stan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Dowdy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="310" to="315" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">The design, synthesis and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">A</forename><surname>Wender</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Pattabiraman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">T</forename><surname>Pelkey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Steinman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Rothbard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="13003" to="13008" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">A</forename><surname>Wender</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Goun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">R</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">H</forename><surname>Pillow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Rothbard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Shinde</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="10340" to="10345" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">B</forename><surname>Wyman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Nicol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Zelphati</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">V</forename><surname>Scaria</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Plank</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">C</forename><surname>Szoka</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="3008" to="3017" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">S</forename><surname>Zatsepin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">S</forename><surname>Oretskaya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Gait</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Pharmaceutical Design</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="3639" to="3654" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Zeineddine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Papadimou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Chebli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Gineste</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Grey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dev Cell</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="535" to="546" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ziegler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Drug Deliv Rev</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="580" to="597" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ziegler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Nervi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Dürrenberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Seelig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="138" to="148" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
